Forward Science Continues to Lead the Fight Against Oral Cancer with OralID

Houston, TX (May 2024) – In 2024, more than 2 million new cancer cases are expected to be diagnosed in the US. Despite advancements in technology and increased awareness, oral cancer remains an outlier, as survival rates have not increased for over three decades. Oral cancer is preventable and highly treatable when discovered early, yet it continues to claim countless lives due to late-stage diagnosis. Forward Science is proud to celebrate its eleventh Oral Cancer Awareness Month by reaffirming its commitment to changing lives with its flagship product, OralID. 

Oral cancer rates are on the rise in the U.S., yet awareness remains low. Many people associate oral cancer with older individuals who smoke or use tobacco, but this reality is changing. The fastest-growing group developing oral cancer are young non-smokers. April's Oral Cancer Awareness Month is dedicated to educating and motivating the public to get screened in order to increase the likelihood of early diagnosis, and ultimately enhancing the quality of life for clinicians, patients, and communities worldwide. OralID has revolutionized screening for oral cancer, providing clinicians with a tool to visualize abnormalities that may not be visible under the naked eye in traditional examinations. 

“At Forward Science, we recognize that oral cancer awareness is not limited to a single month but is a year-round imperative,” emphasizes Robert J. Whitman, CEO of Forward Science. “Through educational efforts and the advanced technology of OralID, we believe our partnership with healthcare professionals can change more lives through the visualization of lesions that may be pre-cancerous.” 

In 2014, Forward Science received FDA clearance for its life changing device, OralID. A decade later, OralID devices are used by clinicians worldwide in effort to change the trends in oral cancer. But for the Forward Science team, this is just the beginning. "As we celebrate Oral Cancer Awareness Month, we are reminded of the impact we've made and are inspired to continue pushing the boundaries of innovation in oral healthcare," adds Whitman.


About Forward Science 
Forward Science is a privately held MedTech company based in Houston, Texas. Forward Science was founded in 2012 by two biomedical engineers with the goal of innovating technology to change more lives. Forward Science’s flagship product, OralID, is an awardwinning oral cancer screening device that allows clinicians to visualize abnormalities that may not be seen under traditional examinations. With the success of OralID, Forward Science continued to focus on moving science forward in the oral healthcare industry by launching advance products to help patients reach their optimal oral health: SalivaMAX, BioStōm, TheraStōm and OxiStōm. Phone: 855.696.7254 

Being completely vertically integrated, Forward Science designs, develops, manufactures, commercializes, and supports their products in-house, ensuring the highest quality of standards coupled with superior service. Forward Science has quickly evolved into the industry leader for providing oral healthcare products worldwide. Join Forward Science’s goal to change lives! For more information, follow us on social media, visit www.ForwardScience.com, or call 855.696.7254